查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1954693

敗血症診斷市場規模、佔有率、成長及全球產業分析：依類型、應用和地區劃分的洞察與預測（2026-2034年）

Sepsis Diagnostics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 185 Pages | 商品交期: 請詢問到貨日

價格

敗血症診斷市場成長驅動因素

2025年全球膿毒症診斷市場規模為 10.0395億美元，預計將從2026年的10.9922億美元成長至2034年的23.9934億美元，預測期內（2026-2034年）年複合成長率（CAGR）為 10%。北美地區在2025年佔據市場主導地位，市場佔有率達 51.50%。這主要受疾病高發病率、有利的償付政策以及先進診斷技術的快速普及所驅動。

敗血症是一種危及生命的疾病，由人體對感染的過度反應引起，可導致組織損傷、器官衰竭甚至死亡。雖然細菌感染是最常見的原因，但病毒和真菌感染也可能導致敗血症。此疾病分為三個階段：敗血症、重症敗血症和敗血性休克。根據世界衛生組織（WHO）統計，2017年全球約有 4,900萬人感染敗血症，1,100萬人死亡，凸顯了早期準確診斷的緊迫性。

市場動態

全球膿毒症發生率的上升是市場成長的主要驅動因素。光是在美國，每年就有約 170萬成年人罹患敗血症，約 35萬人在住院或安寧療護期間死亡。住院率上升和醫療相關感染（HAI）的增加進一步推動了對可靠診斷解決方案的需求。

優惠的償付政策，尤其是在已開發國家，為住院和診斷程序提供了支持。此外，全球膿毒症聯盟和世界衛生組織等國際組織擴大了宣傳活動，有助於早期發現和推廣標準化治療方案。

2020年，由於感染患者中膿毒症發生率的增加，COVID-19 疫情對市場產生了輕微的正面影響。到2021年，患者就診量和公司收入已恢復到疫情前水準，支撐了整個預測期內的穩定成長。

主要市場趨勢

敗血症診斷市場的一個顯著趨勢是快速診斷和即時檢測（POC）技術的日益普及。與傳統方法相比，這些解決方案能夠提供更快、更準確的結果，實現及時的臨床干預。快速檢測減少了對大型實驗室基礎設施和熟練人員的依賴，緩解了許多醫療系統面臨的勞動力短缺問題。

2023年11月，Inflammatix完成了其TriVerity急性感染和膿毒症檢測系統的技術開發，獲得了美國FDA的突破性醫療器械認定，並加速了其商業化進程。此類技術進步顯著提高了診斷的速度和效率。

成長因素

全球膿毒症病例的快速成長持續推動著對有效診斷解決方案的需求。住院患者尤其脆弱，研究表明，約三分之一的醫院死亡病例與敗血症有關。醫療系統日益沉重的負擔進一步加劇了對早期檢測技術的需求。

新興市場意識的提高也促進了市場擴張。各國政府和非政府組織正努力推廣篩檢計畫、教育和敗血症應對方案，以降低死亡率。諸如全球孕產婦敗血症研究與運動（GLOSS）等倡議促進全球對敗血症的認識不斷提高，並推廣診斷方法。

抑制因子

儘管成長前景廣闊，但高昂的診斷成本是推廣應用的一大障礙。敗血症的診斷通常需要進行多項檢測，增加了總成本。例如，英國每年與敗血症相關的直接和間接成本估計為 92.4億美元。在新興市場，單一檢測的費用可能成為患者的經濟負擔，並限制他們獲得及時診斷的機會。

此外，缺乏單一的確診檢測方法以及對複雜臨床評估的依賴也帶來了營運方面的挑戰。

市場區隔分析

依產品類型

試劑和耗材細分市場佔據主導地位，在2026年的市場佔有率達到 77.22%，這主要得益於醫院和實驗室的持續需求。由於技術進步和新產品的推出，儀器領域預計將保持穩定成長。

依技術劃分

由於血液培養的廣泛應用和成本效益，微生物學領域在2026年佔據了58.85%的市場佔有率。免疫分析佔據了第二大佔有率，但分子診斷因其高靈敏度和快速出結果而備受關注。

依方法劃分

由於其高特異性和快速病原體檢測能力，預計自動化檢測在2026年將佔據93.26%的主導市場佔有率。傳統方法由於價格實惠，在低收入地區仍然很重要。

依偵測類型劃分

由於住院率和重症監護室（ICU）入院率高，實驗室檢測佔據主導地位。然而，由於其成本效益高且能快速提供結果，即時檢測預計將呈現最高的成長率。

依病原體分類

細菌感染仍然是敗血症的主要原因，因此細菌感染佔據最大市場佔有率。真菌診斷是第二大細分市場。

依最終使用者分類

醫院和診所佔據市場主導地位。這主要是由於加護病房（ICU）收治人數眾多以及院內診斷需求量大。

區域洞察

到2025年，北美將繼續引領市場，市場規模將達到 5.171億美元。強大的醫療保健基礎設施、技術創新和政府支持推動該地區的成長。

歐洲將佔據第二大市場，這得益於監管審批和熟練的專業人員。由於公眾意識的提高、臨床指南的更新（例如日本的J-SSCG2021）以及醫療基礎設施的不斷完善，亞太地區預計將迎來顯著成長。

主要行業參與者

主要參與者包括 bioMerieux SA、Danaher、Thermo Fisher Scientific Inc.、BD、Abbott、Siemens Healthcare GmbH、T2 Biosystems、Luminex Corporation（DiaSorin S.p.A.）和 Bruker。策略聯盟、監管審批和產品上市增強它們的競爭地位。

目錄

第1章 引言

第2章 執行摘要

第3章 市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機會
  • 市場趨勢

第4章 主要發現

  • 主要地區膿毒症發生率（2025年）
  • 新產品上市
  • 主要產業發展動態（併購、合作等）
  • 敗血症診斷技術進步
  • 主要地區的監管和償付情況
  • 新冠疫情的影響敗血症診斷市場

第5章 全球敗血症診斷市場分析、洞察與預測（2021-2034）

  • 依產品類型劃分的市場分析、洞察與預測
    • 設備
    • 試劑和耗材
  • 依技術劃分的市場分析、洞察與預測
    • 微生物學
    • 分子診斷
    • 免疫分析
    • 其他
  • 依方法劃分的市場分析、洞察與預測
    • 傳統方法
    • 自動化方法
  • 依檢測類型劃分的市場分析、洞察與預測
    • 實驗室檢測
    • 即時檢測
  • 依病原體劃分的市場分析、洞察與預測
    • 細菌
    • 真菌
    • 其他病原體
  • 依最終用戶劃分的市場分析、洞察與預測
    • 醫院和診所
    • 診斷中心
    • 其他
  • 依地區劃分的市場分析、洞察與預測
    • 北美洲
    • 歐洲
    • 亞太地區
    • 世界其他地區

第6章 北美敗血症診斷市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第7章 歐洲敗血症診斷市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 其他歐洲國家

第8章 亞太地區敗血症診斷市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 其他亞太地區

第9章 全球其他地區敗血症診斷市場分析、洞察與預測（2021-2034）

第10章 競爭分析

  • 全球市場佔有率分析（2025）
  • 公司簡介
    • T2 Biosystems, Inc.
    • Danaher
    • Abbott
    • bioMerieux SA
    • Thermo Fisher Scientific Inc.
    • Luminex Corporation（DiaSorin S.p.A.）
    • BD（Becton, Dickinson, and Company）
    • Bruker
    • Siemens Healthcare GmbH
Product Code: FBI107417

Growth Factors of sepsis diagnostics Market

The global sepsis diagnostics market size was valued at USD 1,003.95 million in 2025 and is projected to grow from USD 1,099.22 million in 2026 to USD 2,399.34 million by 2034, exhibiting a CAGR of 10.20% during the forecast period (2026-2034). North America dominated the market in 2025, accounting for a 51.50% share, driven by high disease incidence, favorable reimbursement policies, and rapid adoption of advanced diagnostic technologies.

Sepsis is a life-threatening condition caused by the body's extreme response to infection, leading to tissue damage, organ failure, and potentially death. Bacterial infections are the most common cause, though viral and fungal infections can also trigger the condition. The three stages include sepsis, severe sepsis, and septic shock. According to the World Health Organization (WHO), approximately 49 million people were affected globally in 2017, resulting in 11 million deaths, highlighting the urgent need for early and accurate diagnostics.

Market Dynamics

The rising global incidence of sepsis is a major factor driving market growth. In the U.S. alone, around 1.7 million adults develop sepsis annually, with nearly 350,000 deaths occurring during hospitalization or hospice care. Increased hospitalization rates and healthcare-associated infections (HAIs) further elevate demand for reliable diagnostic solutions.

Favorable reimbursement policies, especially in developed countries, support hospital admissions and diagnostic procedures. Additionally, growing awareness initiatives by global organizations such as the Global Sepsis Alliance and WHO are promoting early detection and standardized treatment protocols.

The COVID-19 pandemic had a slightly positive impact on the market in 2020 due to increased sepsis incidence among infected patients. By 2021, patient visits and company revenues returned to pre-pandemic levels, supporting stable growth through the forecast period.

Key Market Trends

A prominent trend in the sepsis diagnostics market is the increasing adoption of rapid diagnostic and point-of-care (POC) technologies. These solutions provide faster and more accurate results compared to conventional methods, enabling timely clinical intervention. Rapid tests reduce dependency on extensive laboratory infrastructure and skilled personnel, addressing workforce shortages in many healthcare systems.

In November 2023, Inflammatix completed technical development of its TriVerity Acute Infection and Sepsis Test System and received U.S. FDA Breakthrough Device Designation, accelerating commercialization efforts. Such technological advancements are significantly enhancing diagnostic speed and efficiency.

Growth Drivers

The exponential rise in global sepsis cases continues to fuel demand for effective diagnostic solutions. Hospitalized patients are particularly vulnerable, with studies indicating that nearly one in three hospital deaths involves sepsis. The increasing burden on healthcare systems strengthens the need for early detection technologies.

Growing awareness in emerging markets further contributes to market expansion. Government and non-government initiatives are promoting screening programs, education, and implementation of sepsis bundles to reduce mortality. Campaigns such as the Global Maternal Sepsis Study and Campaign (GLOSS) are improving awareness and encouraging diagnostic adoption globally.

Restraining Factors

Despite strong growth prospects, high diagnostic costs limit broader adoption. Sepsis diagnosis typically requires multiple tests, increasing overall expenses. For example, annual direct and indirect costs related to sepsis in the U.K. are estimated at USD 9.24 billion. In emerging countries, individual test costs can create financial burdens for patients, restricting access to timely diagnosis.

Additionally, the absence of a single definitive diagnostic test and reliance on combined clinical assessments pose operational challenges.

Market Segmentation Analysis

By Product Type

The reagents & consumables segment dominated with a 77.22% market share in 2026, driven by recurring demand across hospitals and laboratories. The instruments segment is projected to grow steadily due to technological advancements and new product launches.

By Technology

The microbiology segment accounted for 58.85% of the market share in 2026, owing to widespread use of blood cultures and cost-effectiveness. Immunoassays represent the second-largest segment, while molecular diagnostics are gaining traction due to higher sensitivity and faster results.

By Method

The automated segment held a dominant 93.26% share in 2026, attributed to high specificity and rapid pathogen detection capabilities. Conventional methods maintain relevance in low-income settings due to affordability.

By Test Type

Laboratory tests dominate due to high hospitalization rates and ICU admissions. However, point-of-care tests are expected to witness the highest growth rate due to their cost-effectiveness and rapid results.

By Pathogen

The bacterial segment holds the largest share, as bacterial infections remain the leading cause of sepsis. Fungal diagnostics represent the second-largest segment.

By End User

Hospitals & clinics dominate the market, given the high volume of ICU admissions and in-hospital diagnostics.

Regional Insights

In 2025, North America generated USD 517.1 million, maintaining market leadership. Strong healthcare infrastructure, technological innovation, and government support drive regional growth.

Europe ranks as the second-largest market, supported by regulatory approvals and skilled professionals. Asia Pacific is projected to experience significant growth due to rising awareness, updated clinical guidelines (such as Japan's J-SSCG 2021), and expanding healthcare infrastructure.

Key Industry Players

Leading companies include bioMerieux SA, Danaher, Thermo Fisher Scientific Inc., BD, Abbott, Siemens Healthcare GmbH, T2 Biosystems, Luminex Corporation (DiaSorin S.p.A.), and Bruker. Strategic partnerships, regulatory approvals, and product launches are strengthening competitive positioning.

Conclusion

The global sepsis diagnostics market is poised for strong expansion, growing from USD 1,003.95 million in 2025 to USD 2,399.34 million by 2034, at a CAGR of 10.20%. Increasing disease prevalence, rapid adoption of automated and point-of-care diagnostics, and strong awareness initiatives are driving growth. Although high diagnostic costs pose challenges, technological advancements and global healthcare improvements are expected to sustain long-term market expansion across key regions.

Segmentation By Product Type

  • Instruments
  • Reagents & Consumables

By Technology

  • Microbiology
  • Molecular Diagnostics
  • Immunoassays
  • Others

By Method

  • Conventional
  • Automated

By Test Type

  • Laboratory Tests
  • Point-of-Care Tests

By Pathogen

  • Bacterial
  • Fungal
  • Others

By End User

  • Hospitals & Clinics
  • Diagnostic Centers
  • Others

By Region

  • North America (By Product Type, Technology, Method, Test Type, Pathogen, End User, and Country)
    • U.S. (By Product Type)
    • Canada (By Product Type)
  • Europe (By Product Type, Technology, Method, Test Type, Pathogen, End User, and Country/Sub-Region)
    • Germany (By Product Type)
    • U.K. (By Product Type)
    • France (By Product Type)
    • Italy (By Product Type)
    • Spain (By Product Type)
    • Rest of Europe (By Product Type)
  • Asia Pacific (By Product Type, Technology, Method, Test Type, Pathogen, End User, and Country/Sub-Region)
    • China (By Product Type)
    • India (By Product Type)
    • Japan (By Product Type)
    • Australia (By Product Type)
    • Rest of Asia Pacific (By Product Type)
  • Rest of the World (By Product Type, Technology, Method, Test Type, Pathogen, and End User)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Sepsis Incidence, By Key Regions, 2025
  • 4.2. New Product Launches
  • 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
  • 4.4. Technological Advancements in Sepsis Diagnostics
  • 4.5. Regulatory & Reimbursement Scenario, Key Regions
  • 4.6. Impact of COVID-19 Pandemic on Sepsis Diagnostics Market

5. Global Sepsis Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Instruments
    • 5.1.2. Reagents & Consumables
  • 5.2. Market Analysis, Insights and Forecast - By Technology
    • 5.2.1. Microbiology
    • 5.2.2. Molecular Diagnostics
    • 5.2.3. Immunoassays
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By Method
    • 5.3.1. Conventional
    • 5.3.2. Automated
  • 5.4. Market Analysis, Insights and Forecast - By Test Type
    • 5.4.1. Laboratory Tests
    • 5.4.2. Point-of-Care Tests
  • 5.5. Market Analysis, Insights and Forecast - By Pathogen
    • 5.5.1. Bacterial
    • 5.5.2. Fungal
    • 5.5.3. Other Pathogens
  • 5.6. Market Analysis, Insights and Forecast - By End User
    • 5.6.1. Hospitals & Clinics
    • 5.6.2. Diagnostic Centres
    • 5.6.3. Others
  • 5.7. Market Analysis, Insights and Forecast - By Region
    • 5.7.1. North America
    • 5.7.2. Europe
    • 5.7.3. Asia Pacific
    • 5.7.4. Rest of the World

6. North America Sepsis Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Instruments
    • 6.1.2. Reagents & Consumables
  • 6.2. Market Analysis, Insights and Forecast - By Technology
    • 6.2.1. Microbiology
    • 6.2.2. Molecular Diagnostics
    • 6.2.3. Immunoassays
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By Method
    • 6.3.1. Conventional
    • 6.3.2. Automated
  • 6.4. Market Analysis, Insights and Forecast - By Test Type
    • 6.4.1. Laboratory Tests
    • 6.4.2. Point-of-Care Tests
  • 6.5. Market Analysis, Insights and Forecast - By Pathogen
    • 6.5.1. Bacterial
    • 6.5.2. Fungal
    • 6.5.3. Other Pathogens
  • 6.6. Market Analysis, Insights and Forecast - By End User
    • 6.6.1. Hospitals & Clinics
    • 6.6.2. Diagnostic Centres
    • 6.6.3. Others
  • 6.7. Market Analysis, Insights and Forecast - By Country
    • 6.7.1. U.S.
      • 6.7.1.1. By Product Type
    • 6.7.2. Canada
      • 6.7.2.1. By Product Type

7. Europe Sepsis Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Instruments
    • 7.1.2. Reagents & Consumables
  • 7.2. Market Analysis, Insights and Forecast - By Technology
    • 7.2.1. Microbiology
    • 7.2.2. Molecular Diagnostics
    • 7.2.3. Immunoassays
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By Method
    • 7.3.1. Conventional
    • 7.3.2. Automated
  • 7.4. Market Analysis, Insights and Forecast - By Test Type
    • 7.4.1. Laboratory Tests
    • 7.4.2. Point-of-Care Tests
  • 7.5. Market Analysis, Insights and Forecast - By Pathogen
    • 7.5.1. Bacterial
    • 7.5.2. Fungal
    • 7.5.3. Other Pathogens
  • 7.6. Market Analysis, Insights and Forecast - By End User
    • 7.6.1. Hospitals & Clinics
    • 7.6.2. Diagnostic Centres
    • 7.6.3. Others
  • 7.7. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.7.1. Germany
      • 7.7.1.1. By Product Type
    • 7.7.2. U.K.
      • 7.7.2.1. By Product Type
    • 7.7.3. France
      • 7.7.3.1. By Product Type
    • 7.7.4. Spain
      • 7.7.4.1. By Product Type
    • 7.7.5. Italy
      • 7.7.5.1. By Product Type
    • 7.7.6. Rest of Europe
      • 7.7.6.1. By Product Type

8. Asia Pacific Sepsis Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Instruments
    • 8.1.2. Reagents & Consumables
  • 8.2. Market Analysis, Insights and Forecast - By Technology
    • 8.2.1. Microbiology
    • 8.2.2. Molecular Diagnostics
    • 8.2.3. Immunoassays
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By Method
    • 8.3.1. Conventional
    • 8.3.2. Automated
  • 8.4. Market Analysis, Insights and Forecast - By Test Type
    • 8.4.1. Laboratory Tests
    • 8.4.2. Point-of-Care Tests
  • 8.5. Market Analysis, Insights and Forecast - By Pathogen
    • 8.5.1. Bacterial
    • 8.5.2. Fungal
    • 8.5.3. Other Pathogens
  • 8.6. Market Analysis, Insights and Forecast - By End User
    • 8.6.1. Hospitals & Clinics
    • 8.6.2. Diagnostic Centres
    • 8.6.3. Others
  • 8.7. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.7.1. China
      • 8.7.1.1. By Product Type
    • 8.7.2. India
      • 8.7.2.1. By Product Type
    • 8.7.3. Japan
      • 8.7.3.1. By Product Type
    • 8.7.4. Australia
      • 8.7.4.1. By Product Type
    • 8.7.5. Rest of Asia Pacific
      • 8.7.5.1. By Product Type

9. Rest of the World Sepsis Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Instruments
    • 9.1.2. Reagents & Consumables
  • 9.2. Market Analysis, Insights and Forecast - By Technology
    • 9.2.1. Microbiology
    • 9.2.2. Molecular Diagnostics
    • 9.2.3. Immunoassays
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By Method
    • 9.3.1. Conventional
    • 9.3.2. Automated
  • 9.4. Market Analysis, Insights and Forecast - By Test Type
    • 9.4.1. Laboratory Tests
    • 9.4.2. Point-of-Care Tests
  • 9.5. Market Analysis, Insights and Forecast - By Pathogen
    • 9.5.1. Bacterial
    • 9.5.2. Fungal
    • 9.5.3. Other Pathogens
  • 9.6. Market Analysis, Insights and Forecast - By End User
    • 9.6.1. Hospitals & Clinics
    • 9.6.2. Diagnostic Centres
    • 9.6.3. Others

10. Competitive Analysis

  • 10.1. Global Market Share Analysis (2025)
  • 10.2. Company Profiles
    • 10.2.1. T2 Biosystems, Inc.
      • 10.2.1.1. Overview
      • 10.2.1.2. Product
      • 10.2.1.3. SWOT Analysis
      • 10.2.1.4. Recent Developments
      • 10.2.1.5. Strategies
      • 10.2.1.6. financials (Based on Availability)
    • 10.2.2. Danaher
      • 10.2.2.1. Overview
      • 10.2.2.2. Product
      • 10.2.2.3. SWOT Analysis
      • 10.2.2.4. Recent Developments
      • 10.2.2.5. Strategies
      • 10.2.2.6. financials (Based on Availability)
    • 10.2.3. Abbott
      • 10.2.3.1. Overview
      • 10.2.3.2. Product
      • 10.2.3.3. SWOT Analysis
      • 10.2.3.4. Recent Developments
      • 10.2.3.5. Strategies
      • 10.2.3.6. financials (Based on Availability)
    • 10.2.4. bioMerieux SA
      • 10.2.4.1. Overview
      • 10.2.4.2. Product
      • 10.2.4.3. SWOT Analysis
      • 10.2.4.4. Recent Developments
      • 10.2.4.5. Strategies
      • 10.2.4.6. financials (Based on Availability)
    • 10.2.5. Thermo Fisher Scientific Inc.
      • 10.2.5.1. Overview
      • 10.2.5.2. Product
      • 10.2.5.3. SWOT Analysis
      • 10.2.5.4. Recent Developments
      • 10.2.5.5. Strategies
      • 10.2.5.6. financials (Based on Availability)
    • 10.2.6. Luminex Corporation (DiaSorin S.p.A.)
      • 10.2.6.1. Overview
      • 10.2.6.2. Product
      • 10.2.6.3. SWOT Analysis
      • 10.2.6.4. Recent Developments
      • 10.2.6.5. Strategies
      • 10.2.6.6. financials (Based on Availability)
    • 10.2.7. BD (Becton, Dickinson, and Company)
      • 10.2.7.1. Overview
      • 10.2.7.2. Product
      • 10.2.7.3. SWOT Analysis
      • 10.2.7.4. Recent Developments
      • 10.2.7.5. Strategies
      • 10.2.7.6. financials (Based on Availability)
    • 10.2.8. Bruker
      • 10.2.8.1. Overview
      • 10.2.8.2. Product
      • 10.2.8.3. SWOT Analysis
      • 10.2.8.4. Recent Developments
      • 10.2.8.5. Strategies
      • 10.2.8.6. financials (Based on Availability)
    • 10.2.9. Siemens Healthcare GmbH
      • 10.2.9.1. Overview
      • 10.2.9.2. Product
      • 10.2.9.3. SWOT Analysis
      • 10.2.9.4. Recent Developments
      • 10.2.9.5. Strategies
      • 10.2.9.6. financials (Based on Availability)

List of Tables

  • Table 01: Global Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 02: Global Sepsis Diagnostics Market Revenue (USD million) Forecast, By Technology, 2021-2034
  • Table 03: Global Sepsis Diagnostics Market Revenue (USD million) Forecast, By Method, 2021-2034
  • Table 04: Global Sepsis Diagnostics Market Revenue (USD million) Forecast, By Test Type, 2021-2034
  • Table 05: Global Sepsis Diagnostics Market Revenue (USD million) Forecast, By Pathogen, 2021-2034
  • Table 06: Global Sepsis Diagnostics Market Revenue (USD million) Forecast, By End User, 2021-2034
  • Table 07: Global Sepsis Diagnostics Market Revenue (USD million) Forecast, By Region, 2021-2034
  • Table 08: North America Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 09: North America Sepsis Diagnostics Market Revenue (USD million) Forecast, By Technology, 2021-2034
  • Table 10: North America Sepsis Diagnostics Market Revenue (USD million) Forecast, By Method, 2021-2034
  • Table 11: North America Sepsis Diagnostics Market Revenue (USD million) Forecast, By Test Type, 2021-2034
  • Table 12: North America Sepsis Diagnostics Market Revenue (USD million) Forecast, By Pathogen, 2021-2034
  • Table 13: North America Sepsis Diagnostics Market Revenue (USD million) Forecast, By End User, 2021-2034
  • Table 14: North America Sepsis Diagnostics Market Revenue (USD million) Forecast, By Country, 2021-2034
  • Table 15: U.S. Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 16: Canada Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 17: Europe Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 18: Europe Sepsis Diagnostics Market Revenue (USD million) Forecast, By Technology, 2021-2034
  • Table 19: Europe Sepsis Diagnostics Market Revenue (USD million) Forecast, By Method, 2021-2034
  • Table 20: Europe Sepsis Diagnostics Market Revenue (USD million) Forecast, By Test Type, 2021-2034
  • Table 21: Europe Sepsis Diagnostics Market Revenue (USD million) Forecast, By Pathogen, 2021-2034
  • Table 22: Europe Sepsis Diagnostics Market Revenue (USD million) Forecast, By End User, 2021-2034
  • Table 23: Europe Sepsis Diagnostics Market Revenue (USD million) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 24: Germany Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 25: U.K. Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 26: France Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 27: Italy Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 28: Spain Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 29: Rest of Europe Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 30: Asia Pacific Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 31: Asia Pacific Sepsis Diagnostics Market Revenue (USD million) Forecast, By Technology, 2021-2034
  • Table 32: Asia Pacific Sepsis Diagnostics Market Revenue (USD million) Forecast, By Method, 2021-2034
  • Table 33: Asia Pacific Sepsis Diagnostics Market Revenue (USD million) Forecast, By Test Type, 2021-2034
  • Table 34: Asia Pacific Sepsis Diagnostics Market Revenue (USD million) Forecast, By Pathogen, 2021-2034
  • Table 35: Asia Pacific Sepsis Diagnostics Market Revenue (USD million) Forecast, By End User, 2021-2034
  • Table 36: Asia Pacific Sepsis Diagnostics Market Revenue (USD million) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 37: China Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 38: India Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 39: Japan Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 40: Australia Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 41: Rest of Asia Pacific Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 42: Rest of the World Sepsis Diagnostics Market Revenue (USD million) Forecast, By Product Type, 2021-2034
  • Table 43: Rest of the World Sepsis Diagnostics Market Revenue (USD million) Forecast, By Technology, 2021-2034
  • Table 44: Rest of the World Sepsis Diagnostics Market Revenue (USD million) Forecast, By Method, 2021-2034
  • Table 45: Rest of the World Sepsis Diagnostics Market Revenue (USD million) Forecast, By Test Type, 2021-2034
  • Table 46: Rest of the World Sepsis Diagnostics Market Revenue (USD million) Forecast, By Pathogen, 2021-2034
  • Table 47: Rest of the World Sepsis Diagnostics Market Revenue (USD million) Forecast, By End User, 2021-2034

List of Figures

  • Figure 01: Global Sepsis Diagnostics Market Revenue Breakdown (USD Billion, %), By Region, 2025 & 2034
  • Figure 02: Global Sepsis Diagnostics Market Value Share (%), By Product Type, 2025 & 2034
  • Figure 03: Global Sepsis Diagnostics Market Value Share (%), By Technology, 2025 & 2034
  • Figure 04: Global Sepsis Diagnostics Market Value Share (%), By Method, 2025 & 2034
  • Figure 05: Global Sepsis Diagnostics Market Value Share (%), By Test Type, 2025 & 2034
  • Figure 06: Global Sepsis Diagnostics Market Value Share (%), By Pathogen, 2025 & 2034
  • Figure 07: Global Sepsis Diagnostics Market Value Share (%), By End User, 2025 & 2034
  • Figure 08: Global Sepsis Diagnostics Market Value Share (%), By Region, 2025 & 2034
  • Figure 09: North America Sepsis Diagnostics Market Value (USD million), By Product Type, 2025 & 2034
  • Figure 10: North America Sepsis Diagnostics Market Value Share (%), By Product Type, 2025
  • Figure 11: North America Sepsis Diagnostics Market Value (USD million), By Technology, 2025 & 2034
  • Figure 12: North America Sepsis Diagnostics Market Value Share (%), By Technology, 2025
  • Figure 13: North America Sepsis Diagnostics Market Value (USD million), By Method, 2025 & 2034
  • Figure 14: North America Sepsis Diagnostics Market Value Share (%), By Method, 2025
  • Figure 15: North America Sepsis Diagnostics Market Value (USD million), By Test Type, 2025 & 2034
  • Figure 16: North America Sepsis Diagnostics Market Value Share (%), By Test Type, 2025
  • Figure 17: North America Sepsis Diagnostics Market Value (USD million), By Pathogen, 2025 & 2034
  • Figure 18: North America Sepsis Diagnostics Market Value Share (%), By Pathogen, 2025
  • Figure 19: North America Sepsis Diagnostics Market Value (USD million), By End User, 2025 & 2034
  • Figure 20: North America Sepsis Diagnostics Market Value Share (%), By End User, 2025
  • Figure 21: North America Sepsis Diagnostics Market Value (USD million), By Country, 2025 & 2034
  • Figure 22: North America Sepsis Diagnostics Market Value Share (%), By Country, 2025
  • Figure 23: Europe Sepsis Diagnostics Market Value (USD million), By Product Type, 2025 & 2034
  • Figure 24: Europe Sepsis Diagnostics Market Value Share (%), By Product Type, 2025
  • Figure 25: Europe Sepsis Diagnostics Market Value (USD million), By Technology, 2025 & 2034
  • Figure 26: Europe Sepsis Diagnostics Market Value Share (%), By Technology, 2025
  • Figure 27: Europe Sepsis Diagnostics Market Value (USD million), By Method, 2025 & 2034
  • Figure 28: Europe Sepsis Diagnostics Market Value Share (%), By Method, 2025
  • Figure 29: Europe Sepsis Diagnostics Market Value (USD million), By Test Type, 2025 & 2034
  • Figure 30: Europe Sepsis Diagnostics Market Value Share (%), By Test Type, 2025
  • Figure 31: Europe Sepsis Diagnostics Market Value (USD million), By Pathogen, 2025 & 2034
  • Figure 32: Europe Sepsis Diagnostics Market Value Share (%), By Pathogen, 2025
  • Figure 33: Europe Sepsis Diagnostics Market Value (USD million), By End User, 2025 & 2034
  • Figure 34: Europe Sepsis Diagnostics Market Value Share (%), By End User, 2025
  • Figure 35: Europe Sepsis Diagnostics Market Value (USD million), By Country/Sub-Region, 2025 & 2034
  • Figure 36: Europe Sepsis Diagnostics Market Value Share (%), By Country/Sub-Region, 2025
  • Figure 37: Asia Pacific Sepsis Diagnostics Market Value (USD million), By Product Type, 2025 & 2034
  • Figure 38: Asia Pacific Sepsis Diagnostics Market Value Share (%), By Product Type, 2025
  • Figure 39: Asia Pacific Sepsis Diagnostics Market Value (USD million), By Technology, 2025 & 2034
  • Figure 40: Asia Pacific Sepsis Diagnostics Market Value Share (%), By Technology, 2025
  • Figure 41: Asia Pacific Sepsis Diagnostics Market Value (USD million), By Method, 2025 & 2034
  • Figure 42: Asia Pacific Sepsis Diagnostics Market Value Share (%), By Method, 2025
  • Figure 43: Asia Pacific Sepsis Diagnostics Market Value (USD million), By Test Type, 2025 & 2034
  • Figure 44: Asia Pacific Sepsis Diagnostics Market Value Share (%), By Test Type, 2025
  • Figure 45: Asia Pacific Sepsis Diagnostics Market Value (USD million), By Pathogen, 2025 & 2034
  • Figure 46: Asia Pacific Sepsis Diagnostics Market Value Share (%), By Pathogen, 2025
  • Figure 47: Asia Pacific Sepsis Diagnostics Market Value (USD million), By End User, 2025 & 2034
  • Figure 48: Asia Pacific Sepsis Diagnostics Market Value Share (%), By End User, 2025
  • Figure 49: Asia Pacific Sepsis Diagnostics Market Value (USD million), By Country/ Sub-Region, 2025 & 2034
  • Figure 50: Asia Pacific Sepsis Diagnostics Market Value Share (%), By Country/ Sub-Region, 2025
  • Figure 51: Rest of the World Sepsis Diagnostics Market Value (USD million), By Product Type, 2025 & 2034
  • Figure 52: Rest of the World Sepsis Diagnostics Market Value Share (%), By Product Type, 2025
  • Figure 53: Rest of the World Sepsis Diagnostics Market Value (USD million), By Technology, 2025 & 2034
  • Figure 54: Rest of the World Sepsis Diagnostics Market Value Share (%), By Technology, 2025
  • Figure 55: Rest of the World Sepsis Diagnostics Market Value (USD million), By Method, 2025 & 2034
  • Figure 56: Rest of the World Sepsis Diagnostics Market Value Share (%), By Method, 2025
  • Figure 57: Rest of the World Sepsis Diagnostics Market Value (USD million), By Test Type, 2025 & 2034
  • Figure 58: Rest of the World Sepsis Diagnostics Market Value Share (%), By Test Type, 2025
  • Figure 59: Rest of the World Sepsis Diagnostics Market Value (USD million), By Pathogen, 2025 & 2034
  • Figure 60: Rest of the World Sepsis Diagnostics Market Value Share (%), By Pathogen, 2025
  • Figure 61: Rest of the World Sepsis Diagnostics Market Value (USD million), By End User, 2025 & 2034
  • Figure 62: Rest of the World Sepsis Diagnostics Market Value Share (%), By End User, 2025